Cardiff Oncology, Inc. (CRDF)
1.37
+0.07
(+5.38%)
USD |
NASDAQ |
Sep 18, 16:00
1.37
0.00 (0.00%)
After-Hours: 20:00
Cardiff Oncology Price : 1.37 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 1.29 | 1.39 | 1.285 | 1.37 | 742260.0 |
| Sep 17, 2026 | 1.36 | 1.38 | 1.26 | 1.30 | 1.135M |
| Sep 16, 2026 | 1.35 | 1.38 | 1.31 | 1.35 | 1.855M |
| Sep 15, 2026 | 1.42 | 1.505 | 1.31 | 1.34 | 3.168M |
| Sep 14, 2026 | 1.23 | 1.337 | 1.215 | 1.31 | 2.101M |
| Sep 11, 2026 | 1.21 | 1.22 | 1.172 | 1.21 | 493355.0 |
| Sep 10, 2026 | 1.05 | 1.22 | 1.030 | 1.21 | 750051.0 |
| Sep 09, 2026 | 1.08 | 1.08 | 1.02 | 1.05 | 715985.0 |
| Sep 08, 2026 | 1.05 | 1.13 | 1.05 | 1.10 | 708190.0 |
| Sep 04, 2026 | 1.08 | 1.10 | 1.065 | 1.09 | 437328.0 |
| Sep 03, 2026 | 1.07 | 1.09 | 1.04 | 1.08 | 376194.0 |
| Sep 02, 2026 | 1.04 | 1.09 | 1.01 | 1.06 | 701874.0 |
| Sep 01, 2026 | 1.01 | 1.07 | 1.00 | 1.03 | 838847.0 |
| Aug 31, 2026 | 0.9401 | 1.01 | 0.9026 | 0.9936 | 593645.0 |
| Aug 28, 2026 | 0.9903 | 0.9941 | 0.9334 | 0.94 | 528696.0 |
| Aug 27, 2026 | 0.98 | 0.9995 | 0.98 | 0.9861 | 202827.0 |
| Aug 26, 2026 | 1.02 | 1.025 | 0.9824 | 0.9841 | 274692.0 |
| Aug 25, 2026 | 1.00 | 1.065 | 0.9801 | 1.02 | 918593.0 |
| Aug 24, 2026 | 0.935 | 1.05 | 0.93 | 0.998 | 1.690M |
| Aug 21, 2026 | 0.9266 | 0.9289 | 0.88 | 0.8801 | 653486.0 |
| Aug 20, 2026 | 0.91 | 0.92 | 0.8735 | 0.9087 | 554193.0 |
| Aug 19, 2026 | 0.89 | 0.91 | 0.88 | 0.8979 | 565839.0 |
| Aug 18, 2026 | 0.9031 | 0.9300 | 0.8670 | 0.8861 | 597130.0 |
| Aug 17, 2026 | 0.95 | 0.963 | 0.90 | 0.9043 | 586865.0 |
| Aug 14, 2026 | 0.9768 | 1.02 | 0.96 | 0.963 | 481303.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.29 |
| Alnylam Pharmaceuticals, Inc. | 239.56 |
| Anika Therapeutics, Inc. | 20.81 |
| Savara, Inc. | 5.37 |
| Vericel Corp. | 40.02 |
Price Related Metrics
| PS Ratio | 183.08 |
| Price to Book Value | 3.537 |
| Earnings Yield | -43.11% |
| Market Cap | 93.85M |